Swift Biosciences
Integrated DNA Technologies Acquires Swift Biosciences
The acquisition is IDT's first since being bought by Danaher and is a departure from its previous acquisitions of oligo synthesis businesses.
Swift Biosciences, BillionToOne Partner to Commercialize COVID-19 Test
BillionToOne's assay detects SARS-CoV-2 in samples from nasal, nasopharyngeal, and oropharyngeal swabs and has a testing capacity of 1 million tests per day.
Swift Biosciences, Arbor Biosciences Partner on Targeted NGS Workflow for SARS-CoV-2
The workflow combines Swift's Adaptase technology and RNA library kits with Arbor's myBaits technology for hybridization-based target enrichment of the virus.
Swift Biosciences, LGC BioSearch Partner on Targeted Sequencing for Ag-Bio
LGC will be Swift's worldwide partner for amplicon-based targeted sequencing assays for genotyping AgBio samples, including crop species and animals.
Jun 29, 2017
Swift Biosciences Raises $12.2M
Oct 17, 2013